Investing Profile

Sakae Asanuma

InvestorVC

President & CEO at Taiho Ventures

Your Intro Paths to Sakae Asanuma

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Sakae Asanuma on

Current Investing Position

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Current Fund Size

$150M

Sakae Asanuma is on these Sector & Stage Rankings

Sakae Asanuma's Investments On Record (8)

Company	StageDateRound Size	Total Raised
Normunity	Series BJan 2025$75M	$140M
Co-investors: Tim Shannon (Canaan Partners), Paulina Hill (Polaris Partners), Sara Nayeem (Avoro Ventures)
Anavo Therapeutics	SeedMay 2023$9M SeedApr 2021$24M	$33M
Co-investors: Therese Liechtenstein (M Ventures (Merck)), Debora Dumont (Bioqube Ventures), Simone Botti (INKEF Capital)
Cellvie	SeedFeb 2023$6M	$6M
Dren Bio	Series BJun 2022$65M Series AOct 2020$60M	$130M
Co-investors: Chandra Leo (Hbm Partners), Rajeev Dadoo (SR One), Andrew Schiff (Aisling Capital)
Axial Biotherapeutics	Series COct 2021$37M Series BJun 2019$10M	$86M
Co-investors: James Blair (Domain Associates), Nora Frey (Seventure Partners), Rich Aldrich (Longwood Fund)
Orna Therapeutics	Series AFeb 2021$80M	$320M
Co-investors: Ansbert Gadicke (MPM Capital), Shinichiro Fuse
Theolytics	Series AJan 2021$7M	$7M
Co-investors: Therese Liechtenstein (M Ventures (Merck))
Storm Therapeutics	Series AMay 2019$18M Series AJan 2018$5M	$69M
Co-investors: Hakan Goker (M Ventures (Merck)), Bruno Montanari (Seroba Life Sciences)